Data from Malaysia's Ivermectin study involving 500 COVID-19 patients show no difference in the rate of progression to severe stage. There are 3x more adverse events with Ivermectin, mostly having diarrhoea.
infection and could not be recommended for inclusion in current treatment guidelines, said a Health Ministry study.
One received a five-day course of Ivermectin plus standard of care , and the other was the standard of care group that were treated according to MoH guidelines for COVID-19 patients at 20 government hospitals and MAEPS 2.0 Quarantine and COVID-19 Treatment Centre . Dr Noor Hisham said that safety analysis showed three times more adverse events were reported in the IVM group versus the SOC group, most commonly diarrhoea, while there was a trend of 28-day mortality reduction by IVM with standard of care, but not reaching statistical significance.
ICR director, Dr Kalaiarasu M. Peariasamy, said the I-TECH findings showed that patients in the IVM group compared to the SOC group had similar rates of progression to severe COVID-19 disease at 21.2 per cent and 17.3 per cent respectively.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dr Noor Hisham: Health Ministry study finds Ivermectin ineffective at treating Covid-19, but likely to cause diarrhoea | Malay MailKUALA LUMPUR, Nov 3 — Livestock deworming medication Ivermectin did not significantly reduce the effects of severe Covid-19 infection and could not be recommended for inclusion in current treatment guidelines, said a Health Ministry study. Health director-general Tan Sri Dr Noor Hisham Abdullah...
Read more »
Ivermectin tidak sesuai rawat pesakit Covid-19 - Utusan DigitalHasil dapatan kajian Ivermectin (I-TECH) juga selari dengan kajian berskala besar seperti Ivercor-Covid-19 dari Argentina dan Together dari Brazil yang tidak menyokong penggunaan rutin ivermectin dalam amalan klinikal rawatan Covid-19.
Read more »
Health Ministry: Study shows Ivermectin does not prevent severe cases of Covid-19PETALING JAYA: A clinical study conducted by the Institute of Clinical Research (ICR) shows that the anti-viral drug Ivermectin does not prevent severe cases of Covid-19, says the Health Ministry.
Read more »